Bevacizumab. Anti-VEGF monoclonal antibody, avastin, rhumab-VEGF.
D020533:Angiogenesis Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D015179:Colorectal Neoplasms / Q000188:drug therapy; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors